Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Correspondence] Fixed-dose combinations for hypertension

Globally, 1·4 billion people have hypertension, of whom less than 15% have their blood pressure appropriately controlled1 and, as a result, elevated blood pressure is a leading cause of death globally, killing more than 10 million people a year. In low-income and middle-income countries, more than 70% of the treated patients with hypertension have uncontrolled blood pressure. One major reason for low levels of control is that most patients only receive monotherapy,1,2 although evidence suggests that most patients require two drugs or more to achieve optimal and sustained blood pressure control.